Professional Support

Webcast: Managing ADHD year-round, including summers and holidays
Hosted by Dr. Patricia Quinn, this free on-demand Webcast and live Q&A series offers important information on managing ADHD in pediatric patients year-round, including transitions between the school year and summer vacation.


Medical Education Grants

Medical Economic Podcasts: Staying Current
Listen and learn, at your convenience, to podcasts covering a broad range of medical hot topics including practice management, professional development, personnel and ethics issues and more.


Medical Education Grants
Healthcare professionals can go here, to the McNeil Pediatrics™ company Web site, for more information on medical education grants. Educational grants are administered by Ortho-McNeil Janssen Scientific Affairs, LLC (OMJSA) for McNeil Pediatrics™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc and are independent of the Sales and Marketing functions of McNeil Pediatrics™.


Interactive Learning
Explore the challenges your pediatric and adult patients face throughout the day and help them better manage their ADHD symptoms with in our interactive, online ADHD learning center.


Videocasts
These presentations from some of the top names in the ADHD field of ADHD cover a variety of topics related to ADHD, and can be accessed online whenever your schedule permits.


Live Discussion with a Representative
Take advantage of an interactive, online discussion with a e-Customer representative at a time that is convenient for you.

 

CONCERTA® is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).

IMPORTANT SAFETY INFORMATION

CONCERTA® should not be taken by patients with: allergies to methylphenidate or other ingredients in CONCERTA®; significant anxiety, tension, or agitation; glaucoma; Tourette's syndrome, tics, or family history of Tourette's syndrome; current or recent use of monoamine oxidase inhibitors (MAOIs). Children under 6 years of age should not take CONCERTA.®

Abuse of methylphenidate may lead to dependence. CONCERTA® should not be used in patients with known structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, coronary artery disease, other serious cardiac problems, or patients with pre-existing severe gastrointestinal narrowing. Use with caution in patients with hypertension and other cardiovascular conditions, psychosis, bipolar disorder, and history of seizures/EEG abnormalities. Stimulants may cause new psychotic or manic symptoms; discontinuation of treatment may be appropriate. Aggressive behavior or hostility should be monitored in patients beginning ADHD treatment. Methylphenidate may produce difficulties with visual accommodation and blurring of vision. Hematologic monitoring is advised during prolonged therapy. Growth should be monitored during treatment with stimulants, and patients who are not growing or gaining height or weight as expected may need to have their treatment interrupted.

The most common adverse reaction (>5%) reported in children and adolescents was abdominal pain upper. The most common adverse reactions (>10%) reported in adults were dry mouth, nausea, decreased appetite, headache, and insomnia.

Please see full U.S. Prescribing Information

© Ortho-McNeil-Janssen Pharmaceuticals, Inc. 2010. All rights reserved. Your use of the information on this site is subject to the terms of our Legal Notice. Please see our Privacy Policy. This site is published by McNeil Pediatrics™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. which is solely responsible for its contents.

This information is intended for the use of our customers and healthcare professionals in the United States and Puerto Rico only. McNeil Pediatrics™ recognizes that the Internet is a global communications medium; however, laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may be not be appropriate for use outside the United States and Puerto Rico.

CONCERTA® and OROS® are registered trademarks of ALZA Corporation © Ortho-McNeil-Janssen Pharmaceuticals, Inc. Titusville, NJ, USA. All rights reserved.

McNeil Pediatrics Logo



Last Modified Date: Jun 15 2010 at 16:01:18 EDT